Skip to menu Skip to content Skip to footer

2001

Journal Article

Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants

Staatz, Christine E., Taylor, Paul J., Lynch, Stephen V., Willis, Charlene, Charles, Bruce G. and Tett, Susan E. (2001). Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants. Transplantation, 72 (6), 1056-1061. doi: 10.1097/00007890-200109270-00013

Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants

2001

Journal Article

Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation

Staatz, C, Taylor, P and Tett, S (2001). Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation. Nephrology Dialysis Transplantation, 16 (9), 1905-1909. doi: 10.1093/ndt/16.9.1905

Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation

2000

Journal Article

Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

Collins, D., Coombes, J., Staatz, C. E., Stowasser, D. and Stowasser, M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-52.

Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

2000

Journal Article

Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

Stowasser, Danielle A., Staatz, Christine E., Stowasser, Michael, Coombes, Judith A. and Collins, David M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-53. doi: 10.1002/jppr200030247

Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

1998

Journal Article

Ester prodrugs of a potent analgesic, morphine-6-sulfate: syntheses, spectroscopic and physicochemical properties

PreechagoonD, BreretonI, Staatz, C and PrankerdR (1998). Ester prodrugs of a potent analgesic, morphine-6-sulfate: syntheses, spectroscopic and physicochemical properties. International Journal of Pharmaceutics, 163 (1-2), 177-190. doi: 10.1016/S0378-5173(97)00381-5

Ester prodrugs of a potent analgesic, morphine-6-sulfate: syntheses, spectroscopic and physicochemical properties